News
Public · Published
PRIM Q3 2026 deep dive: renewables project delays and margin reset drive outlook revision
Primoris reported Q3 2026 revenue of $1.95 billion, down 10.4% year on year and below analyst expectations. Adjusted profit was $1.20 per share, above estimates, but the company lowered its full-year adjusted profit forecast to $2.18 per share at the midpoint. Management cited renewables project cost overruns and regulatory delays that deferred projects and reduced revenue.
Published:
Updated:
What happened
Primoris reported Q3 2026 revenue of $1.95 billion, down 10.4% year on year and below analyst expectations. Adjusted profit was $1.20 per share, above estimates, but the company lowered its full-year adjusted profit forecast to $2.18 per share at the midpoint. Management cited renewables project cost overruns and regulatory delays that deferred projects and reduced revenue.
Confirmed
Global impact / market context
The mix of a quarterly profit beat and a lower annual forecast points to pressure beyond the reported quarter. Renewables project overruns can raise delivery costs, while regulatory delays defer customer work and revenue; if these challenges persist, they could constrain profit growth despite a sizable backlog.
Analyst inference
Primoris's backlog reached $14.07 billion, up 27.2% year on year, suggesting substantial contracted work, but that does not ensure timely execution or revenue recognition. The 4.9% operating margin, down from 6.3%, highlights weaker operating returns even as adjusted EBITDA exceeded estimates.
Analyst inference
What to watch
- Watch whether Primoris completes deferred renewables projects and contains cost overruns; better execution could convert delayed work into revenue without further pressure on operating returns. Analyst inference
- Compare later revenue and operating margin with this quarter's results to see whether the decline and lower margin persist or improve as projects advance. Analyst inference
- Track management's full-year adjusted profit forecast of $2.18 per share at the midpoint and EBITDA forecast of $300 million for signs of further revision. Confirmed